Swu‐Jane Lin

6.4k total citations · 5 hit papers
87 papers, 5.0k citations indexed

About

Swu‐Jane Lin is a scholar working on Geriatrics and Gerontology, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Swu‐Jane Lin has authored 87 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Geriatrics and Gerontology, 12 papers in Epidemiology and 12 papers in Economics and Econometrics. Recurrent topics in Swu‐Jane Lin's work include Pharmaceutical Practices and Patient Outcomes (16 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Bone health and treatments (7 papers). Swu‐Jane Lin is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (16 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Bone health and treatments (7 papers). Swu‐Jane Lin collaborates with scholars based in United States, Taiwan and Switzerland. Swu‐Jane Lin's co-authors include Yea‐Huei Kao Yang, Jennifer Schranz, Steven M. Teutsch, Ching‐Lan Cheng, Cheng‐Han Lee, Edward Chia‐Cheng Lai, Shih‐Chieh Shao, Cheng‐Yang Hsieh, Chien‐Chou Su and Sheng‐Feng Sung and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Swu‐Jane Lin

80 papers receiving 4.9k citations

Hit Papers

Validation of the national health insurance research da... 2001 2026 2009 2017 2010 2001 2019 2015 2019 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Validation of the national health insurance research database with ischemic stroke cases in Taiwan
    2010 1.2k citations Ching‐Lan Cheng, Yea‐Huei Kao Yang et al. Pharmacoepidemiology and Drug Safety profile →
  2. Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
    2001 1.1k citations Swu‐Jane Lin et al. profile →
  3. <p>Taiwan’s National Health Insurance Research Database: past and future</p>
    2019 853 citations Cheng‐Yang Hsieh, Chien‐Chou Su et al. Clinical Epidemiology profile →
  4. Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan
    2015 244 citations Ching‐Lan Cheng, Swu‐Jane Lin et al. profile →
  5. The Chang Gung Research Database—A multi‐institutional electronic medical records database for real‐world epidemiological studies in Taiwan
    2019 227 citations Shih‐Chieh Shao, Yea‐Huei Kao Yang et al. Pharmacoepidemiology and Drug Safety profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Swu‐Jane Lin United States 24 1.5k 1.2k 653 636 588 87 5.0k
Sara L. Thomas United Kingdom 40 3.3k 2.2× 834 0.7× 784 1.2× 610 1.0× 982 1.7× 78 6.9k
Véronique Sebille France 34 1.1k 0.7× 478 0.4× 575 0.9× 273 0.4× 582 1.0× 164 5.5k
Alex Koyfman United States 35 801 0.5× 1.0k 0.9× 1.2k 1.8× 728 1.1× 693 1.2× 245 4.9k
Matthew S. Freiberg United States 45 1.9k 1.2× 1.7k 1.5× 902 1.4× 1.3k 2.1× 588 1.0× 176 6.7k
Brit Long United States 38 866 0.6× 1.4k 1.2× 1.4k 2.2× 888 1.4× 803 1.4× 419 6.2k
Eric M. Mortensen United States 43 3.0k 1.9× 691 0.6× 806 1.2× 663 1.0× 990 1.7× 178 6.0k
Esther W. Chan Hong Kong 39 678 0.4× 976 0.8× 1.1k 1.7× 1.1k 1.8× 650 1.1× 296 5.7k
Kenneth Nugent United States 38 1.1k 0.7× 706 0.6× 1.1k 1.7× 885 1.4× 1.3k 2.3× 446 6.7k
Anders H. Riis Denmark 39 1.3k 0.8× 430 0.4× 1.2k 1.8× 406 0.6× 438 0.7× 113 4.9k
Eric Yuk Fai Wan Hong Kong 35 813 0.5× 1.3k 1.1× 403 0.6× 589 0.9× 331 0.6× 240 5.3k

Countries citing papers authored by Swu‐Jane Lin

Since Specialization
Citations

This map shows the geographic impact of Swu‐Jane Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swu‐Jane Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swu‐Jane Lin more than expected).

Fields of papers citing papers by Swu‐Jane Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swu‐Jane Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swu‐Jane Lin. The network helps show where Swu‐Jane Lin may publish in the future.

Co-authorship network of co-authors of Swu‐Jane Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Swu‐Jane Lin. A scholar is included among the top collaborators of Swu‐Jane Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swu‐Jane Lin. Swu‐Jane Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Ching‐Lan, et al.. (2025). A Nationwide Cohort Study on Antidepressant Use and Stroke Risk in Young Adults Aged 18–44 Years. Clinical Therapeutics. 47(9). 720–728.
2.
Hsieh, Cheng‐Yang, Shih‐Chieh Shao, Sheng‐Feng Sung, et al.. (2025). Taiwan’s National Health Insurance Research Database (NHIRD): in the Era of Artificial Intelligence, Causal Inference, and Data Security. Clinical Epidemiology. Volume 17. 967–981. 1 indexed citations
3.
Tsai, Daniel Hsiang‐Te, et al.. (2025). Detection of hidden populations using illicit substances. Journal of Epidemiology & Community Health. 79(9). 719–725.
4.
Hsieh, Cheng‐Yang, Po‐Ting Chen, Shih‐Chieh Shao, et al.. (2024). Validating ICD-10 Diagnosis Codes for Guillain-Barré Syndrome in Taiwan’s National Health Insurance Claims Database. Clinical Epidemiology. Volume 16. 733–742. 3 indexed citations
5.
Hsu, Sheng‐Min, Yi-Hsun Huang, Chaw‐Ning Lee, et al.. (2024). Cataract Surgery and Incidence of Retinal Vascular Occlusion: Population-Based Cohort Study Using a Target Trial Emulation Framework. American Journal of Ophthalmology. 268. 143–154.
6.
Tseng, Yu‐Ting, et al.. (2023). A New Drug Safety Signal Detection and Triage System Integrating Sequence Symmetry Analysis and Tree-Based Scan Statistics with Longitudinal Data. Clinical Epidemiology. Volume 15. 91–107. 2 indexed citations
7.
Liao, Shu‐Chen, et al.. (2022). Positive Predictive Value of ICD-10 Codes for Cerebral Venous Sinus Thrombosis in Taiwan&amp;rsquo;s National Health Insurance Claims Database. Dove Medical Press (Taylor and Francis Group). 15 indexed citations
8.
Man, Kenneth K. C., Shih‐Chieh Shao, Han Eol Jeong, et al.. (2021). Cardiovascular and metabolic risk of antipsychotics in children and young adults: a multinational self-controlled case series study. Epidemiology and Psychiatric Sciences. 30. e65–e65. 5 indexed citations
9.
Lai, Edward Chia‐Cheng, et al.. (2015). Comparative risk of oral ulcerations among antipsychotics users - population-based retrospective cohort study. Pharmacoepidemiology and Drug Safety. 25(2). 123–132. 4 indexed citations
10.
Hatoum, Hind T., et al.. (2013). Review of the economic evaluations of hormonal therapy for patients with locally advanced prostate cancer. Expert Review of Pharmacoeconomics & Outcomes Research. 13(2). 251–259. 4 indexed citations
11.
Hatoum, Hind T., Jeffrey Rosen, Anke Fierlinger, Swu‐Jane Lin, & Roy D. Altman. (2013). Assessment of the health-related quality of life impact of Euflexxa® (1% sodium hyaluronate) using the short form (SF)-36 data collected in a randomized clinical trial. Osteoarthritis and Cartilage. 21. S246–S246. 2 indexed citations
12.
Chang, Chia‐Hsien, et al.. (2012). Risk of Insomnia Attributable to β-Blockers in Elderly Patients with Newly Diagnosed Hypertension. Drug Metabolism and Pharmacokinetics. 28(1). 53–58. 13 indexed citations
13.
Hatoum, Hind T., Swu‐Jane Lin, Deborah Buchner, & Edward Kim. (2011). Use of hypomethylating agents and associated care in patients with myelodysplastic syndromes: a claims database study. Current Medical Research and Opinion. 27(6). 1255–1262. 4 indexed citations
14.
Ng, Chip‐Jin, Zui‐Shen Yen, Jeffrey Che-Hung Tsai, et al.. (2010). Validation of the Taiwan triage and acuity scale: a new computerised five-level triage system. Emergency Medicine Journal. 28(12). 1026–1031. 113 indexed citations
15.
Hatoum, Hind T., Kasem S. Akhras, & Swu‐Jane Lin. (2009). The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study. Diagnostic Microbiology and Infectious Disease. 64(3). 305–310. 42 indexed citations
16.
Winkler, Susan, et al.. (2008). Systematic review and meta-analysis of combination therapy for smoking cessation. Journal of the American Pharmacists Association. 48(5). 659–664. 43 indexed citations
17.
Lin, Swu‐Jane & Stephanie Y. Crawford. (2007). An Online Debate Series for First-Year Pharmacy Students. American Journal of Pharmaceutical Education. 71(1). 12–12. 1 indexed citations
18.
Lin, Swu‐Jane & Stephanie Y. Crawford. (2007). An Online Debate Series for First-Year Pharmacy Students. American Journal of Pharmaceutical Education. 71(1). 12–12. 41 indexed citations
19.
Lin, Swu‐Jane, et al.. (2006). Appeals System and Its Outcomes in National Health Insurance in Taiwan. Annals of Pharmacotherapy. 40(3). 506–511. 6 indexed citations
20.
Lin, Swu‐Jane, et al.. (2003). A Patient Empowerment Model to Prevent Medication Errors. Journal of Medical Systems. 27(6). 503–517. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara L. Thomas Breakdown of academic impact, for papers by Véronique Sebille Breakdown of academic impact, for papers by Alex Koyfman Breakdown of academic impact, for papers by Matthew S. Freiberg Breakdown of academic impact, for papers by Brit Long Breakdown of academic impact, for papers by Eric M. Mortensen Breakdown of academic impact, for papers by Esther W. Chan Breakdown of academic impact, for papers by Kenneth Nugent Breakdown of academic impact, for papers by Anders H. Riis Breakdown of academic impact, for papers by Eric Yuk Fai Wan
Rankless by CCL
2026